Comparison of upfront transplantation and pretransplant cytoreductive therapy for advanced myelodysplastic syndrome
Background - Allogeneic hematopoietic stem cell transplantation (allo-HSCT) is the only curative therapy for advanced myelodysplastic syndrome (MDS). However, the value of pretransplant cytoreduction remains debatable. - Patients and Methods - We retrospectively compared the outcomes of upfront tran...
Gespeichert in:
| Hauptverfasser: | , , , , , , , , , |
|---|---|
| Dokumenttyp: | Article (Journal) |
| Sprache: | Englisch |
| Veröffentlicht: |
September 2021
|
| In: |
Clinical lymphoma, myeloma & leukemia
Year: 2021, Jahrgang: 21, Heft: 9, Pages: 631-640 |
| ISSN: | 2152-2669 |
| DOI: | 10.1016/j.clml.2021.04.015 |
| Online-Zugang: | Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1016/j.clml.2021.04.015 Verlag, lizenzpflichtig, Volltext: https://www.sciencedirect.com/science/article/pii/S2152265021001749 
|
| Verfasserangaben: | Hong Wang, Yan Li, Qingyu Xu, Wei Zhou, Chengliang Yin, Ruiqi Wang, Mengzhen Wang, Yuanyuan Xu, Yonghui Li, Li Yu |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1832508234 | ||
| 003 | DE-627 | ||
| 005 | 20240326080438.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 230126s2021 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.clml.2021.04.015 |2 doi | |
| 035 | |a (DE-627)1832508234 | ||
| 035 | |a (DE-599)KXP1832508234 | ||
| 035 | |a (OCoLC)1389538123 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Wang, Hong |e VerfasserIn |0 (DE-588)1279224622 |0 (DE-627)1832502287 |4 aut | |
| 245 | 1 | 0 | |a Comparison of upfront transplantation and pretransplant cytoreductive therapy for advanced myelodysplastic syndrome |c Hong Wang, Yan Li, Qingyu Xu, Wei Zhou, Chengliang Yin, Ruiqi Wang, Mengzhen Wang, Yuanyuan Xu, Yonghui Li, Li Yu |
| 264 | 1 | |c September 2021 | |
| 300 | |a 10 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Gesehen am 26.01.2023 | ||
| 520 | |a Background - Allogeneic hematopoietic stem cell transplantation (allo-HSCT) is the only curative therapy for advanced myelodysplastic syndrome (MDS). However, the value of pretransplant cytoreduction remains debatable. - Patients and Methods - We retrospectively compared the outcomes of upfront transplantation and pretransplant cytoreduction. Of 69 patients, 39 received upfront allo-HSCT and 30 received pretransplant cytoreduction, including chemotherapy (n = 16), hypomethylating agents (HMAs, n = 6), and HMAs with chemotherapy (n = 8). - Results - The upfront group achieved similar overall survival (OS) and a trend of better progression-free survival (PFS) from diagnosis compared with the cytoreduction group (3-year PFS, 64.0% vs. 44.4%, P = .076). Posttransplant outcomes were comparable between the two groups in terms of OS, relapse-free survival (RFS), cumulative incidence of relapse (CIR), and non-relapse mortality (NRM). In patients with ≥2 mutations, the upfront group achieved better OS and PFS (3-year OS, 100.0% vs. 68.6%, P = .044; 3-year PFS: 92.3% vs. 43.9%, P = .016) than the cytoreduction group. Patients achieving remission in the cytoreduction group had outcomes similar to the upfront group, but those without remission before transplantation had a significantly worse posttransplant OS (3-year OS, 46.7% vs. 75.7%, P = .038). Patients with pretransplant HMAs had better PFS than those with chemotherapy or HMAs plus chemotherapy (P < 0.05). - Conclusion - Compared with pretransplant cytoreduction, upfront allo-HSCT might provide more benefit to some patients with advanced MDS if there are suitable donors. HMAs would be a good alternative during the donor search. | ||
| 650 | 4 | |a Allogeneic hematopoietic stem cell transplantation | |
| 650 | 4 | |a Cytoreduction | |
| 650 | 4 | |a Hypomethylating agents | |
| 650 | 4 | |a MDS | |
| 650 | 4 | |a Upfront | |
| 700 | 1 | |a Li, Yan |e VerfasserIn |4 aut | |
| 700 | 1 | |a Xu, Qingyu |d 1992- |e VerfasserIn |0 (DE-588)1257157019 |0 (DE-627)1801237581 |4 aut | |
| 700 | 1 | |a Zhou, Wei |e VerfasserIn |4 aut | |
| 700 | 1 | |a Yin, Chengliang |e VerfasserIn |4 aut | |
| 700 | 1 | |a Wang, Ruiqi |e VerfasserIn |4 aut | |
| 700 | 1 | |a Wang, Mengzhen |e VerfasserIn |4 aut | |
| 700 | 1 | |a Xu, Yuanyuan |e VerfasserIn |4 aut | |
| 700 | 1 | |a Li, Yonghui |e VerfasserIn |4 aut | |
| 700 | 1 | |a Yu, Li |e VerfasserIn |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Clinical lymphoma, myeloma & leukemia |d Amsterdam [u.a.] : Elsevier, 2010 |g 21(2021), 9 vom: Sept., Seite 631-640 |h Online-Ressource |w (DE-627)620142014 |w (DE-600)2540998-0 |w (DE-576)358408776 |x 2152-2669 |7 nnas |a Comparison of upfront transplantation and pretransplant cytoreductive therapy for advanced myelodysplastic syndrome |
| 773 | 1 | 8 | |g volume:21 |g year:2021 |g number:9 |g month:09 |g pages:631-640 |g extent:10 |a Comparison of upfront transplantation and pretransplant cytoreductive therapy for advanced myelodysplastic syndrome |
| 856 | 4 | 0 | |u https://doi.org/10.1016/j.clml.2021.04.015 |x Verlag |x Resolving-System |z lizenzpflichtig |3 Volltext |
| 856 | 4 | 0 | |u https://www.sciencedirect.com/science/article/pii/S2152265021001749 |x Verlag |z lizenzpflichtig |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20230126 | ||
| 993 | |a Article | ||
| 994 | |a 2021 | ||
| 998 | |g 1257157019 |a Xu, Qingyu |m 1257157019:Xu, Qingyu |d 60000 |d 61200 |e 60000PX1257157019 |e 61200PX1257157019 |k 0/60000/ |k 1/60000/61200/ |p 4 | ||
| 999 | |a KXP-PPN1832508234 |e 4252188466 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"origin":[{"dateIssuedKey":"2021","dateIssuedDisp":"September 2021"}],"id":{"doi":["10.1016/j.clml.2021.04.015"],"eki":["1832508234"]},"name":{"displayForm":["Hong Wang, Yan Li, Qingyu Xu, Wei Zhou, Chengliang Yin, Ruiqi Wang, Mengzhen Wang, Yuanyuan Xu, Yonghui Li, Li Yu"]},"physDesc":[{"extent":"10 S."}],"relHost":[{"title":[{"title_sort":"Clinical lymphoma, myeloma & leukemia","title":"Clinical lymphoma, myeloma & leukemia"}],"recId":"620142014","language":["eng"],"note":["Gesehen am 04.02.20"],"disp":"Comparison of upfront transplantation and pretransplant cytoreductive therapy for advanced myelodysplastic syndromeClinical lymphoma, myeloma & leukemia","type":{"bibl":"periodical","media":"Online-Ressource"},"part":{"year":"2021","issue":"9","pages":"631-640","text":"21(2021), 9 vom: Sept., Seite 631-640","volume":"21","extent":"10"},"titleAlt":[{"title":"Clinical lymphoma, myeloma and leukemia"}],"pubHistory":["10.2010 -"],"id":{"zdb":["2540998-0"],"eki":["620142014"],"issn":["2152-2669"]},"origin":[{"dateIssuedKey":"2010","publisher":"Elsevier ; CIG Media Group","dateIssuedDisp":"2010-","publisherPlace":"Amsterdam [u.a.] ; Dallas, Tex."}],"physDesc":[{"extent":"Online-Ressource"}]}],"title":[{"title_sort":"Comparison of upfront transplantation and pretransplant cytoreductive therapy for advanced myelodysplastic syndrome","title":"Comparison of upfront transplantation and pretransplant cytoreductive therapy for advanced myelodysplastic syndrome"}],"person":[{"given":"Hong","family":"Wang","role":"aut","display":"Wang, Hong","roleDisplay":"VerfasserIn"},{"role":"aut","display":"Li, Yan","roleDisplay":"VerfasserIn","given":"Yan","family":"Li"},{"display":"Xu, Qingyu","roleDisplay":"VerfasserIn","role":"aut","family":"Xu","given":"Qingyu"},{"roleDisplay":"VerfasserIn","display":"Zhou, Wei","role":"aut","family":"Zhou","given":"Wei"},{"role":"aut","display":"Yin, Chengliang","roleDisplay":"VerfasserIn","given":"Chengliang","family":"Yin"},{"role":"aut","display":"Wang, Ruiqi","roleDisplay":"VerfasserIn","given":"Ruiqi","family":"Wang"},{"family":"Wang","given":"Mengzhen","roleDisplay":"VerfasserIn","display":"Wang, Mengzhen","role":"aut"},{"roleDisplay":"VerfasserIn","display":"Xu, Yuanyuan","role":"aut","family":"Xu","given":"Yuanyuan"},{"family":"Li","given":"Yonghui","display":"Li, Yonghui","roleDisplay":"VerfasserIn","role":"aut"},{"role":"aut","display":"Yu, Li","roleDisplay":"VerfasserIn","given":"Li","family":"Yu"}],"note":["Gesehen am 26.01.2023"],"type":{"media":"Online-Ressource","bibl":"article-journal"},"language":["eng"],"recId":"1832508234"} | ||
| SRT | |a WANGHONGLICOMPARISON2021 | ||